Bionano Genomics, Inc. / Fundamentals
Income statement
- Net revenue
€23.63M - Cost of goods sold
€22.03M - Gross profit
€1.60M - SG&A expenses
€33.25M - R&D expenses
€11.62M - EBITDA
-€59.39M - D&A
€9.10M - EBIT
-€62.12M - Interest expenses
€144.74K - EBT
-€64.00M - Tax expenses
€24.12K - Net income
-€64.04M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€25.35M - Changes in working capital
€2.35M - Operating cash flow
-€22.46M - Capex
€0.00 - Other investing cash flow
€0.00 - Net investing cash flow
-€12.46M - Total cash dividends paid
€0.00 - Issuance of common stock
€28.64M - Debt repayment
-€5.64M - Other financing cash flow
-€3.80M - Net financing cash flow
€19.19M - Foreign exchange effects
-€11.20K - Net change in cash
-€15.74M - Cash at end of period
€3.07M - Free cash flow
-€22.46M
Balance sheet
- Cash and cash equivalents
€3.07M - Cash and short-term investments
€14.16M - Total receivables
€3.01M - Inventory
€7.44M - Other current assets
€12.15M - Total current assets
€36.76M - Property, plant & equipment
€20.88M - Goodwill
€0.00 - Intangible assets
€6.05M - Long-term investments
€0.00 - Other non-current assets
€1.80M - Total non-current assets
€28.73M - Total assets
€65.49M - Accounts payable
€5.38M - Short-term debt
€11.51M - Other current liabilities
€2.44M - Total current liabilities
€20.83M - Long-term debt
€5.35M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€5.56M - Total liabilities
€26.39M - Common stock
€0.00 - Retained earnings
-€605.83M - Other equity
-€8.62K - Total equity
€39.09M - Total liabilities and shareholders' equity
€65.49M
Company information
- Market capitalization
€9.44M - Employees
98 - Enterprise Value
€27.14M
Company ratios
- Gross margin
-
6.8% Much better than peer group: -84.2% - EBITDA margin
-
-251.3% Much better than peer group: -508.0% - EBIT margin
-
-262.9% Much better than peer group: -497.7% - EBT margin
-
-270.9% Much better than peer group: -383.3% - Net margin
-
-271.0% Much better than peer group: -545.6% - ROE
-
-163.8% Much worse than peer group: 216.9% - ROA
-
-97.8% Much better than peer group: -124.3% - Asset turnover
-
36.1% Much worse than peer group: 75.7% - FCF margin
-
-95.0% Much better than peer group: -686.6% - FCF yield
-237.9% - Efficiency ratio
351.3% - Net sales per employee
-
€241.11K - Net income per employee
-
-€653.46K